Successful Stenting Followed by Surgery for Perforated Esophageal Cancer due to Chemotherapy.

Successful Stenting Followed by Surgery for Perforated Esophageal Cancer due to Chemotherapy. Ann Thorac Surg. 2019 May 15;: Authors: Kobayashi T, Makino T, Yamasaki M, Tanaka K, Mori M, Doki Y Abstract Perforation of esophageal cancer solely due to preoperative chemotherapy is extremely rare, but can be associated with pyothorax, and be difficult to treat. Here, we first report the case of successfully-treated patient with thoracic esophageal cancer who developed esophageal perforation during DCF (docetaxel, cisplatin, 5-FU) chemotherapy. A 73-year-old patient developed esophageal perforation on the fourth day of the first DCF cycle. The second cycle of DCF was administered after insertion of esophageal stenting, and subtotal esophagectomy. Early drainage and stent placement were crucial for achieving infection control and allowing for a subsequent complete resection. PMID: 31102633 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research